SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-23-030750
Filing Date
2023-03-09
Accepted
2023-03-09 21:27:35
Documents
1
Period of Report
2023-03-07

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm238905-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm238905-4_4seq1.xml 4 11388
  Complete submission text file 0001104659-23-030750.txt   13010
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CARISMA THERAPEUTICS INC. 3675 MARKET STREET, SUITE 200 PHILADELPHIA PA 19104
Business Address
Klichinsky Michael (Reporting) CIK: 0001967221 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 23721448